Advisornet Financial’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.07M Sell
2,556
-167
-6% -$171K 0.14% 137
2026
Q1
$2.5M Buy
2,723
+312
+13% +$316K 0.13% 147
2025
Q4
$2.59M Buy
2,411
+99
+4% +$94.7K 0.14% 138
2025
Q3
$1.76M Sell
2,312
-113
-5% -$84.1K 0.1% 178
2025
Q2
$1.89M Sell
2,425
-11
-0.5% -$8.55K 0.12% 166
2025
Q1
$2.01M Buy
2,436
+79
+3% +$65.7K 0.15% 157
2024
Q4
$1.82M Sell
2,357
-841
-26% -$696K 0.15% 146
2024
Q3
$2.83M Buy
3,198
+226
+8% +$203K 0.21% 109
2024
Q2
$2.69M Sell
2,972
-36
-1% -$28.8K 0.24% 100
2024
Q1
$2.34M Sell
3,008
-72
-2% -$51.2K 0.23% 108
2023
Q4
$1.8M Buy
3,080
+133
+5% +$77.6K 0.17% 141
2023
Q3
$1.58M Sell
2,947
-799
-21% -$412K 0.14% 152
2023
Q2
$1.76M Sell
3,746
-118
-3% -$49.5K 0.15% 150
2023
Q1
$1.33M Sell
3,864
-123
-3% -$41.5K 0.12% 177
2022
Q4
$1.46M Buy
3,987
+73
+2% +$25.9K 0.14% 157
2022
Q3
$1.26M Sell
3,914
-2
-0.1% -$634 0.13% 176
2022
Q2
$1.27M Buy
3,916
+151
+4% +$45.3K 0.12% 180
2022
Q1
$1.08M Buy
3,765
+854
+29% +$220K 0.07% 236
2021
Q4
$804K Buy
2,911
+163
+6% +$41.3K 0.05% 310
2021
Q3
$635K Buy
2,748
+107
+4% +$26.4K 0.04% 318
2021
Q2
$606K Hold
2,641
0.04% 352
2021
Q1
$493K Buy
2,641
+1
+0% +$196 0.04% 368
2020
Q4
$446K Sell
2,640
-105
-4% -$15.7K 0.04% 365
2020
Q3
$406K Buy
2,745
+10
+0.4% +$1.55K 0.03% 372
2020
Q2
$449K Sell
2,735
-200
-7% -$30.7K 0.04% 359
2020
Q1
$407K Sell
2,935
-35
-1% -$4.81K 0.04% 349
2019
Q4
$390K Sell
2,970
-1,675
-36% -$194K 0.03% 375
2019
Q3
$519K Buy
4,645
+1,761
+61% +$196K 0.05% 324
2019
Q2
$320K Buy
2,884
+1,239
+75% +$146K 0.04% 383
2019
Q1
$213K Sell
1,645
-231
-12% -$28.1K 0.03% 420
2018
Q4
$217K Sell
1,876
-240
-11% -$26.8K 0.03% 389
2018
Q3
$227K Buy
2,116
+14
+0.7% +$1.4K 0.03% 394
2018
Q2
$179K Sell
2,102
-432
-17% -$35.5K 0.02% 420
2018
Q1
$196K Sell
2,534
-14,971
-86% -$1.21M 0.03% 395
2017
Q4
$1.48M Buy
+17,505
New +$1.49M 0.22% 93

Other funds holding LLY

Advisornet Financial's LLY Position: Q2 2026 in Review

Advisornet Financial reduced its Eli Lilly (LLY) stake by 6.1% in Q2 2026, selling an estimated $171K and leaving 2,556 shares worth $3.07M. The position accounts for 0.14% of the portfolio, ranked #137.

Advisornet Financial first reported a position in LLY in Q4 2017 and has held it in 35 quarters since. 1,842 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Advisornet Financial held 2,556 shares of Eli Lilly worth $3.07M as of Q2 2026.
  • Advisornet Financial sold 167 Eli Lilly shares in Q2 2026, an estimated $171K.
  • Eli Lilly made up 0.14% of Advisornet Financial's portfolio in Q2 2026, its #137 holding.
  • Advisornet Financial first reported a position in Eli Lilly in Q4 2017 and has held it in 35 quarters since.
  • 1,842 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Advisornet Financial's 13F filing for Q2 2026, filed 23 Jul 2026.